GOLDMAN SACHS GROUP INC - NEOS THERAPEUTICS INC ownership

NEOS THERAPEUTICS INC's ticker is NEOS and the CUSIP is 64052L106. A total of 42 filers reported holding NEOS THERAPEUTICS INC in Q3 2020. The put-call ratio across all filers is - and the average weighting 0.1%.

Quarter-by-quarter ownership
GOLDMAN SACHS GROUP INC ownership history of NEOS THERAPEUTICS INC
ValueSharesWeighting
Q4 2020$211,000
-84.9%
337,188
-87.2%
0.00%
Q3 2020$1,396,000
-23.0%
2,631,585
-0.6%
0.00%
-100.0%
Q2 2020$1,813,000
-6.7%
2,647,219
+2.1%
0.00%0.0%
Q1 2020$1,944,000
-49.7%
2,592,072
+1.3%
0.00%0.0%
Q4 2019$3,865,000
+7.8%
2,559,374
+5.6%
0.00%0.0%
Q3 2019$3,587,000
+13.9%
2,423,515
-0.7%
0.00%0.0%
Q2 2019$3,149,000
-2.2%
2,441,181
+97.8%
0.00%0.0%
Q1 2019$3,221,000
+456.3%
1,234,014
+251.9%
0.00%
Q4 2018$579,000
+283.4%
350,690
+1029.3%
0.00%
Q3 2018$151,000
-62.1%
31,054
-51.2%
0.00%
Q2 2018$398,000
+44.7%
63,628
+92.0%
0.00%
Q1 2018$275,000
-24.5%
33,135
-7.0%
0.00%
Q4 2017$364,000
+267.7%
35,641
+136.1%
0.00%
Q3 2016$99,000
-10.0%
15,094
+26.8%
0.00%
Q2 2016$110,000
-51.5%
11,905
+10.0%
0.00%
Q3 2015$227,00010,8200.00%
Other shareholders
NEOS THERAPEUTICS INC shareholders Q3 2020
NameSharesValueWeighting ↓
Stonepine Capital Management, LLC 4,962,657$3,100,0002.37%
HUNTER ASSOCIATES INVESTMENT MANAGEMENT LLC 100,000$62,0000.02%
SlateStone Wealth, LLC 62,000$39,0000.01%
Allred Capital Management, LLC 24,995$15,0000.01%
Bridge Advisory, LLC 23,564$15,0000.01%
Livingston Group Asset Management CO (operating as Southport Capital Management) 24,000$15,0000.01%
DEERFIELD MANAGEMENT COMPANY, L.P. (SERIES C) 320,993$201,0000.00%
BRIDGEWAY CAPITAL MANAGEMENT, LLC 229,500$143,0000.00%
Virtu Financial LLC 41,401$26,0000.00%
TSFG, LLC 200$1,0000.00%
View complete list of NEOS THERAPEUTICS INC shareholders